WO1992012992A3 - Basic structural immunogenic polypeptides having epitopes for hcv, antibodies, polynucleotide sequences, vaccines and methods - Google Patents
Basic structural immunogenic polypeptides having epitopes for hcv, antibodies, polynucleotide sequences, vaccines and methods Download PDFInfo
- Publication number
- WO1992012992A3 WO1992012992A3 PCT/US1992/000356 US9200356W WO9212992A3 WO 1992012992 A3 WO1992012992 A3 WO 1992012992A3 US 9200356 W US9200356 W US 9200356W WO 9212992 A3 WO9212992 A3 WO 9212992A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- novel
- polypeptides
- hcv
- immunogenic
- fgb2
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 13
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 13
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 13
- 230000002163 immunogen Effects 0.000 title abstract 7
- 102000040430 polynucleotide Human genes 0.000 title abstract 3
- 108091033319 polynucleotide Proteins 0.000 title abstract 3
- 239000002157 polynucleotide Substances 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 title 1
- 210000002966 serum Anatomy 0.000 abstract 3
- 241001227713 Chiron Species 0.000 abstract 2
- 238000002965 ELISA Methods 0.000 abstract 1
- 208000005176 Hepatitis C Diseases 0.000 abstract 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 abstract 1
- 230000003302 anti-idiotype Effects 0.000 abstract 1
- 230000000692 anti-sense effect Effects 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 210000004899 c-terminal region Anatomy 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 238000001415 gene therapy Methods 0.000 abstract 1
- 208000010710 hepatitis C virus infection Diseases 0.000 abstract 1
- 238000003018 immunoassay Methods 0.000 abstract 1
- 238000003119 immunoblot Methods 0.000 abstract 1
- 238000006386 neutralization reaction Methods 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 238000003259 recombinant expression Methods 0.000 abstract 1
- 239000000523 sample Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
- C07K16/109—Hepatitis C virus; Hepatitis G virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63980991A | 1991-01-14 | 1991-01-14 | |
US639,809 | 1991-01-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1992012992A2 WO1992012992A2 (en) | 1992-08-06 |
WO1992012992A3 true WO1992012992A3 (en) | 1993-03-18 |
Family
ID=24565635
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1992/000356 WO1992012992A2 (en) | 1991-01-14 | 1992-01-14 | Basic structural immunogenic polypeptides having epitopes for hcv, antibodies, polynucleotide sequences, vaccines and methods |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP0571554A1 (en) |
AU (1) | AU1459792A (en) |
WO (1) | WO1992012992A2 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9105871D0 (en) * | 1991-03-20 | 1991-05-08 | Inst Cientifico Tecnol Navarra | Synthetic peptides |
DE4209215A1 (en) | 1991-07-04 | 1993-01-07 | Boehringer Mannheim Gmbh | HCV PEPTIDE ANTIGEN AND METHOD FOR DETERMINING HCV |
WO1993007488A1 (en) * | 1991-10-02 | 1993-04-15 | Eiken Kagaku Kabushiki Kaisha | Reagent and method for testing hepatitis c |
DE4240980A1 (en) * | 1992-08-07 | 1994-02-10 | Boehringer Mannheim Gmbh | HCV peptide antigens and method for the determination of HCV |
JPH06311885A (en) * | 1992-08-25 | 1994-11-08 | Mitsubishi Kasei Corp | Anti-sense compound complementary with gene of hepatitis c virus |
US6174868B1 (en) * | 1992-09-10 | 2001-01-16 | Isis Pharmaceuticals, Inc. | Compositions and methods for treatment of hepatitis C virus-associated diseases |
ATE202383T1 (en) * | 1992-09-10 | 2001-07-15 | Isis Pharmaceuticals Inc | COMPOSITIONS AND METHODS FOR THE TREATMENT OF HEPATITIS C VIRUS-ASSOCIATED DISEASES |
JPH10503364A (en) * | 1994-05-10 | 1998-03-31 | ザ ジェネラル ホスピタル コーポレーション | Antisense inhibition of hepatitis C virus |
AU707811B2 (en) * | 1995-05-05 | 1999-07-22 | Australian Water Technologies Pty Ltd | Method for the detection of viable Cryptosporidium parvum oocysts |
AUPN283195A0 (en) * | 1995-05-05 | 1995-06-01 | Australian Water Technologies Pty Ltd | Method for the detection of viable cryptosporidium parvum cells |
IT1285158B1 (en) * | 1996-09-17 | 1998-06-03 | Angeletti P Ist Richerche Bio | SOLUBLE POLYPEPTIDES WITH THE SERINO-PROTEASIS ACTIVITY OF NS3 OF THE HEPATITIS C VIRUS, AND PROCEDURE FOR THEIR PREPARATION AND |
AU4497999A (en) * | 1998-04-28 | 1999-11-16 | Ingrid-Corina Bergter | Radioimmunopharmaca for treating hepatitis c |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990014436A1 (en) * | 1989-05-18 | 1990-11-29 | Chiron Corporation | Nanbv diagnostics: polynucleotides useful for screening for hepatitis c virus |
EP0442394A2 (en) * | 1990-02-16 | 1991-08-21 | United Biomedical, Inc. | Synthetic peptides specific for the detection of antibodies to HCV, diagnosis of HCV infection and prevention thereof as vaccines |
EP0445423A2 (en) * | 1989-12-22 | 1991-09-11 | Abbott Laboratories | Hepatitis C assay |
EP0451891A2 (en) * | 1990-03-30 | 1991-10-16 | Akzo Nobel N.V. | Peptides immunochemically reactive with antibodies directed against hepatitis Non-A, Non-B virus |
EP0471356A1 (en) * | 1990-08-14 | 1992-02-19 | JAPAN as represented by Director General of Agency of NATIONAL INSTITUTE OF HEALTH | Antigenic peptide for detecting anti-hepatitis C virus antibodies and use thereof |
WO1992002642A1 (en) * | 1990-08-10 | 1992-02-20 | Chiron Corporation | Nanbv diagnostics: polynucleotides useful for screening for hepatitis c virus |
EP0479376A1 (en) * | 1990-10-05 | 1992-04-08 | Akzo Nobel N.V. | Peptides immunochemically reactive with antibodies directed against hepatitis Non-A, Non-B virus |
EP0485209A1 (en) * | 1990-11-08 | 1992-05-13 | Immuno Japan Inc. | Non A, non B hepatitis virus related antigen, antibody detection systems, polynucleotides and polypeptides |
EP0489968A1 (en) * | 1990-12-14 | 1992-06-17 | Innogenetics N.V. | Synthetic antigens for the detection of antibodies to hepatitis C virus |
-
1992
- 1992-01-14 EP EP92907699A patent/EP0571554A1/en not_active Withdrawn
- 1992-01-14 WO PCT/US1992/000356 patent/WO1992012992A2/en not_active Application Discontinuation
- 1992-01-14 AU AU14597/92A patent/AU1459792A/en not_active Abandoned
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990014436A1 (en) * | 1989-05-18 | 1990-11-29 | Chiron Corporation | Nanbv diagnostics: polynucleotides useful for screening for hepatitis c virus |
EP0445423A2 (en) * | 1989-12-22 | 1991-09-11 | Abbott Laboratories | Hepatitis C assay |
EP0442394A2 (en) * | 1990-02-16 | 1991-08-21 | United Biomedical, Inc. | Synthetic peptides specific for the detection of antibodies to HCV, diagnosis of HCV infection and prevention thereof as vaccines |
EP0451891A2 (en) * | 1990-03-30 | 1991-10-16 | Akzo Nobel N.V. | Peptides immunochemically reactive with antibodies directed against hepatitis Non-A, Non-B virus |
WO1992002642A1 (en) * | 1990-08-10 | 1992-02-20 | Chiron Corporation | Nanbv diagnostics: polynucleotides useful for screening for hepatitis c virus |
EP0471356A1 (en) * | 1990-08-14 | 1992-02-19 | JAPAN as represented by Director General of Agency of NATIONAL INSTITUTE OF HEALTH | Antigenic peptide for detecting anti-hepatitis C virus antibodies and use thereof |
EP0479376A1 (en) * | 1990-10-05 | 1992-04-08 | Akzo Nobel N.V. | Peptides immunochemically reactive with antibodies directed against hepatitis Non-A, Non-B virus |
EP0485209A1 (en) * | 1990-11-08 | 1992-05-13 | Immuno Japan Inc. | Non A, non B hepatitis virus related antigen, antibody detection systems, polynucleotides and polypeptides |
EP0489968A1 (en) * | 1990-12-14 | 1992-06-17 | Innogenetics N.V. | Synthetic antigens for the detection of antibodies to hepatitis C virus |
Non-Patent Citations (4)
Title |
---|
Biochemical and Biophysical Research Communications, vol. 172, no. 2, 30 October 1990, Academic Press, Inc., K. MURAISO et al.: "A structural protein of hepatitis C virus expressed in E. coli facilitates accurate detection of hepatitis C virus", pages 511-516, see the whole document * |
Japan. J. Exp. Med., vol. 60, no. 3, June 1990, H. OKAMOTO et al.: "The 5'-terminal sequence of the hepatitis C virus genome", pages 167-177 * |
Journal of General Virology, vol. 71, December 1990, (GB), K. TAKEUCHI et al.: "The putative nucleocapsid and envelope protein genes of hepatitis C virus determined by comparison of the nucleotide sequences of two isolates derived from an experimentally infected chimpanzee and healthy human carriers", pages 3027-3033, see page 3032, column 2, last paragraph * |
Proceedings of the 28th Symposium on Peptide Chemistry, Osaka, 25-27 October 1990, (ed. Y. SHIMONISHI), E. MUNEKATA et al.: "Epitope mapping of hepatitis C virus constituting protein", pages 211-214, see the whole document * |
Also Published As
Publication number | Publication date |
---|---|
EP0571554A1 (en) | 1993-12-01 |
AU1459792A (en) | 1992-08-27 |
WO1992012992A2 (en) | 1992-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2005950C (en) | Non-a, non-b hepatitis virus genome rna, cdna and virus antigen protein | |
UA50829C2 (en) | Polynucleotide, vector, cells, expressing system, polypeptides, monoclonal antibodies, preparation of polyclonal antibodies, nucleotide probe, analytic kits, method for detecting nucleic acids, methods for immunoassay, vaccine, method for production of antibodies | |
US6870032B1 (en) | Assay for the diagnosis of flaviviral infection using antibodies with high affinity for NS1 protein of flavivirus in hexameric form | |
WO1992012992A3 (en) | Basic structural immunogenic polypeptides having epitopes for hcv, antibodies, polynucleotide sequences, vaccines and methods | |
US6054264A (en) | Methods of typing hepatitis C virus and reagents for use therein | |
JP2004512824A5 (en) | ||
HU228873B1 (en) | Hcv antigen/antibody combination assay | |
UA43310C2 (en) | POLYPEPTIDE OF KOREAN TYPE VIRUS HEPATITIS C (KHCV), cDNA (KHCV), POLYNUCLEOTIDE ENCODING POLYPEPTIDE (KHCV), RECOMBINANT EXPRESSING VECTOR, CELL, TRANSFORMED BY VECTOR, POLYPEPTIDE COMPRISING EPITOPE, PROCESS FOR OBTAINING POLYPEPTIDE, DIAGNOSTIC AGENT FOR DETECTING ANTIBODY, DIRECTED AGAINST (KHCV) ANTIGENE, DIAGNOSTIC KIT, DIAGNOSTIC METHOD FOR DETECTING OF ANTIBODY, DIRECTED AGAINST (KHCV) ANTIGENE, MONOCLONAL ANTIBODY, CELL LINE, DIAGNOSTIC AGENT FOR DETECTING OF EPITOPE (KHCV) IN THE SAMPLE, WHICH IS TESTED, METHOD FOR DETECTING OF EPITOPE (KHCV), VACCINE FOR TREATING AND PREVENTION (KHCV) INFECTION (VARIANTS), KIT FOR DETECTING POLYNUCLEOTIDE (KHCV), METHOD FOR DETECTING POLYNUCLEOTIDE FROM KHCV | |
JP2008515388A5 (en) | ||
DK175843B1 (en) | Polypeptides of Surfactant Alvelolar Proteins (ASP), Pharmaceutical Composition Containing the Polypeptide, DNA Expression System Encoding the Polypeptide, and Method of Preparing Polypeptides with ASP Activity | |
US8293528B2 (en) | Peptide compositions and their use in particular in the preparation of pharmaceutical compositions active against the hepatitis C virus | |
JP2001522809A (en) | Host-derived protein-bound HCV: pharmaceutical, diagnostic and purification applications | |
JP2005535287A5 (en) | ||
US5176994A (en) | Non-A, Non-B hepatitis virus genome RNA, cDNA and virus antigen protein | |
EP0516859A1 (en) | Non-a non-b hepatitis virus antigen protein | |
CA2400007C (en) | Immunization of an individual against carcinoma and the preliminary stages thereof | |
KR100210200B1 (en) | Recombinant microorganism which produce hcv e2 protein and preparing method of hcv e2 protein | |
EP0804473A1 (en) | Methods and compositions for differential diagnosis of acute and chronic hepatitis c virus infection | |
ES2280905T3 (en) | NATURAL RUBBER ALLERGEN PROTEIN. | |
KR0158434B1 (en) | Composite peptide for c-type cancer | |
CA2151128A1 (en) | Hepatitis c virus (hcv) non-structural-3 peptides, antibodies thereto and methods for the detection of hcv | |
WO2001029079A1 (en) | IMMUNO-INTERACTIVE FRAGMENTS OF THE αC SUBUNIT OF INHIBIN | |
EP0593291A2 (en) | Nonstructural protein of hepatitis C virus, and diagnostic method and kit using the same | |
Hwang et al. | Detection of cells producing murine interferon‐α using antipeptide antibodies | |
YAGI et al. | An epitope chimeric antigen for the hepatitis C virus serological screening test |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AT AU BB BG BR CA CH CS DE DK ES FI GB HU JP KP KR LK LU MG MN MW NL NO PL RO RU SD SE |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE BF BJ CF CG CH CI CM DE DK ES FR GA GB GN GR IT LU MC ML MR NL SE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AT AU BB BG BR CA CH CS DE DK ES FI GB HU JP KP KR LK LU MG MN MW NL NO PL RO RU SD SE |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE BF BJ CF CG CH CI CM DE DK ES FR GA GB GN GR IT LU MC ML MR NL SE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1992907699 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 1992907699 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: CA |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1992907699 Country of ref document: EP |